๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Treatment of recurrent hepatocellular carcinoma after liver transplantation

โœ Scribed by Eric Davis; Russell Wiesner; Juan Valdecasas; Yoshiaki Kita; Massimo Rossi; Myron Schwartz


Publisher
John Wiley and Sons
Year
2011
Tongue
English
Weight
78 KB
Volume
17
Category
Article
ISSN
1527-6465

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Recurrence of hepatocellular carcinoma a
โœ Sasan Roayaie; Jonathan D. Schwartz; Max W. Sung; Sukru H. Emre; Charles M. Mill ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 103 KB ๐Ÿ‘ 1 views

Very little is known about the natural history, effects of therapy, and survival after recurrence of hepatocellular carcinoma (HCC) after liver transplantation. All adult patients undergoing liver transplant from September 19, 1988, until September 19, 2002, were reviewed. Only patients with histolo

MRI Findings of recurrent hepatocellular
โœ Chang Hee Lee; Lauren M. Brubaker; David A. Gerber; Young Mi Ku; Young Hoon Kim; ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 371 KB ๐Ÿ‘ 1 views

## Abstract ## Purpose To describe the patterns of recurrence and serial magnetic resonance imaging (MRI) features of hepatocellular carcinoma (HCC) after liver transplantation. ## Materials and Methods All cases of recurrent HCC after transplantation between September 2002 and August 2009 that

Impact of sirolimus on the recurrence of
โœ Srinath Chinnakotla; Gary L. Davis; Sugam Vasani; Peter Kim; Koji Tomiyama; Edmu ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 147 KB ๐Ÿ‘ 1 views

Tumor recurrence after liver transplantation for hepatocellular carcinoma is associated with a poor prognosis. Because immunosuppression is a well-known risk factor for tumor growth, it is surprising that its possible role in the outcome of liver transplantation has been poorly evaluated. We perform